At minimum, we recommend collecting and adjusting for: age, sex, tumor type and stage, tumor burden (radiographic or measurable disease), ECOG performance status, baseline systemic inflammation markers (CRP, ESR), recent infections, chemotherapy/immunotherapy history, and concurrent medications known to affect immune parameters (systemic corticosteroids, proton pump inhibitors, immunosuppressants). Here, CRP is linked to neoplasm.